Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Assets: 2011-2018

Historic Assets for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Jun 2018 value amounting to $71.7 million.

  • EyePoint Pharmaceuticals' Assets rose 63.19% to $81.9 million in Q1 2019 from the same period last year, while for Mar 2019 it was $81.9 million, marking a year-over-year increase of 63.19%. This contributed to the annual value of $71.7 million for FY2018, which is 283.73% up from last year.
  • EyePoint Pharmaceuticals' Assets amounted to $71.7 million in FY2018, which was up 283.73% from $18.7 million recorded in FY2017.
  • EyePoint Pharmaceuticals' Assets' 5-year high stood at $71.7 million during FY2018, with a 5-year trough of $18.7 million in FY2017.
  • In the last 3 years, EyePoint Pharmaceuticals' Assets had a median value of $31.6 million in 2016 and averaged $40.7 million.
  • Its Assets has fluctuated over the past 5 years, first tumbled by 40.93% in 2017, then spiked by 283.73% in 2018.
  • EyePoint Pharmaceuticals' Assets (Yearly) stood at $22.7 million in 2014, then skyrocketed by 42.77% to $32.4 million in 2015, then fell by 2.31% to $31.6 million in 2016, then crashed by 40.93% to $18.7 million in 2017, then surged by 283.73% to $71.7 million in 2018.